Work

CX-01, an inhibitor of CXCL12/CXCR4 axis and of platelet factor 4 (PF4), with azacitidine (AZA) in patients with hypomethylating agent (HMA) refractory AML and MDS.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.7027

Authors: Eric Huselton, Amanda F. Cashen, Meagan Jacoby, Iskra Pusic, Rizwan Romee, Geoffrey L. Uy, John F. DiPersio, Peter Westervelt

Institution: Washington University in St. Louis

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890147119

Cites:

Cited by: 4

Related to: 10